Imprint Wealth’s Immix Biopharma IMMX Stock Holding History

Imprint Wealth’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Buy	31,248 +11,239	+56%	+$82.5K	1.3%	22
2025 Q4	$105K	Sell	20,009 -47,414	-70%	-$195K	0.49%	40
2025 Q3	$141K	Buy	+67,423	New	+$162K	0.45%	47
2024 Q1	$76.5K	Sell	26,214 -8,269	-24%	-$32K	0.02%	297
2023 Q4	$143K	Buy	34,483 +11,400	+49%	+$51.6K	0.12%	153
2023 Q3	$78.9K	Buy	23,083 +803	+4%	+$1.88K	0.07%	152
2023 Q2	$42.3K	Buy	+22,280	New	+$46.7K	0.03%	170

Other funds holding IMMX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Imprint Wealth's IMMX Position: Q1 2026 in Review

Imprint Wealth increased its Immix Biopharma (IMMX) stake by 56% in Q1 2026, buying an estimated $82.5K and bringing the position to 31,248 shares worth $285K. The position accounts for 1.3% of the portfolio, ranked #22.

Imprint Wealth first reported a position in IMMX in Q2 2023 and has held it in 7 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

Imprint Wealth held 31,248 shares of Immix Biopharma worth $285K as of Q1 2026.
Imprint Wealth bought 11,239 Immix Biopharma shares in Q1 2026, an estimated $82.5K.
Immix Biopharma made up 1.3% of Imprint Wealth's portfolio in Q1 2026, its #22 holding.
Imprint Wealth first reported a position in Immix Biopharma in Q2 2023 and has held it in 7 quarters since.
77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.